News & Updates

Upper airway hydration via salt mist droplets reduces self-reported symptoms of the coronavirus disease 2019 (COVID-19), a recent study has found.

Adding lenzilumab, a monoclonal antibody targeting GM-CSF, on top of standard supportive care significantly improves survival without the need of invasive mechanical ventilation at 28 days in patients hospitalized with COVID-19 compared with standard care alone, reveals the LIVE-AIR study.

Linezolid-based chemotherapeutic regimens appear to be useful for treating multidrug-resistant spinal tuberculosis in patients who have undergone spinal surgery, according to a study.

While the mRNA vaccines currently available on the market have gained regulatory nods* for use in children aged 5 or 6 years old**, Moderna’s mRNA-1273 vaccine is setting a “new low” by showing that two 25 μg doses of the vaccine induce a robust immune response in infants/children as young as 6 months to <6 years of age, according to the latest data from the KidCOVE study.

Intramuscular vaccination in the deltoid muscle is associated with a small absolute risk for shoulder conditions, suggests a recent study.